바이오플러스

099430 코스닥
5,430 10 (-0.18%)
기준 : 02/13
  • 시가총액
    3,347억
  • 주식수
    6,164만
  • PER
    20.85배
  • PBR
    1.96배
  • ROE
    9.41%
  • 결산월
    12월

25.4Q 업데이트 - 잠정실적

  • 재무분석
  • 20년 재무제표
  • 손익계산서
자세히

손익계산서를 통해 매출액과 비용 그리고 이익(손실) 규모를 알 수 있습니다. 기업의 매출액에서 모든 비용을 제외하고 남는 돈을 순이익이라고 합니다. 순이익이 많을 수록 기업가치는 높아지게 됩니다.
손익계산서를 볼 때는 '많이 팔고 많이 남기는 회사'를 찾으면 됩니다. 경쟁 기업에 비해 매출액 규모가 크고, 순이익을 많이 남기면 경쟁우위에 있는 기업이라고 할 수 있습니다.

  • 데이터
  • 연결 재무제표
  • 국제회계
설정
연환산 연간 분기
세부항목 소수점
단위 : 억원
손익계산서 2025/12 2025/09 2025/06 2025/03 2024/12 2024/09 2024/06 2024/03 2023/12 2023/09 2023/06 2023/03 2022/12 2022/09 2022/06 2022/03 2021/12 2021/09 2021/06 2021/03 2020/12 2020/09 2020/06 2020/03 2019/12 2019/09 2019/06 2019/03 2018/12 2018/09
매출액(수익) 908908.9 968968.0 891891.6 797797.7 664664.1
내수 N/AN/A 327327.2 286286.5 212212.3 180180.5
수출 N/AN/A 640640.7 605605.1 585585.4 483483.5
기타 N/AN/A 00.0 00.0 00.0 00.0
매출원가 N/AN/A 298298.5 300300.7 277277.2 237237.6
원재료 N/AN/A 348348.0 323323.0 265265.3 224224.4
재고자산의변동 N/AN/A -5-5.7 22.4 44.1 33.3
기타원가 N/AN/A N/AN/A -23-23.3 -27-27.4 -55-55.9
인건비 N/AN/A 5454.4 5656.1 5151.4 4141.5
감가상각비 N/AN/A 1919.4 1818.6 1818.2 1717.5
기타 N/AN/A -117-117.6 -76-76.1 -34-34.4 66.6
매출총이익 N/AN/A 669669.4 590590.8 520520.5 426426.4
판매비와관리비 N/AN/A 390390.8 313313.8 237237.0 189189.7
급여 N/AN/A 9393.1 8282.7 7070.9 6060.0
퇴직급여 N/AN/A 66.6 55.3 44.8 33.8
복리후생비 N/AN/A 1414.3 1414.4 1111.7 99.6
임차료 N/AN/A 22.7 33.8 33.1 11.6
수도광열비 N/AN/A 1515.3 77.0 22.0 00.2
전산처리비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지급수수료 N/AN/A 3333.1 2828.1 2525.0 1717.8
용역비 N/AN/A 00.4 00.4 00.3 00.2
수출비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
판매수수료 N/AN/A 7070.6 5353.8 3030.6 1919.0
판매촉진비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
광고선전비 N/AN/A 1717.8 1313.8 1111.2 1010.4
애프터서비스비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
운반비 N/AN/A 55.4 44.6 22.7 22.0
포장비 N/AN/A 11.6 11.3 00.8 00.5
연구개발비 N/AN/A 2828.6 2424.4 1919.8 1414.7
개발비상각 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손상각비 N/AN/A 3131.9 2323.5 1414.2 1515.5
감가상각비 N/AN/A 1717.1 1313.9 1010.8 1010.2
무형자산상각비 N/AN/A 44.3 44.5 44.4 44.3
기타 N/AN/A 4747.4 3131.5 2323.9 1919.3
영업이익 150150.1 278278.6 277277.0 283283.5 236236.6
EBITDA N/AN/A 234234.8 218218.0 238238.7 194194.0
금융손익 N/AN/A -84-84.0 -89-89.0 -65-65.7 -59-59.6
금융수익 N/AN/A 108108.6 109109.0 117117.8 119119.5
이자수익 N/AN/A 88.8 1313.1 1414.7 1717.9
외환거래이익 N/AN/A 1515.5 1212.1 1515.7 1717.2
외환차익 N/AN/A 44.5 44.3 44.8 44.4
외화환산이익 N/AN/A 1010.9 77.8 1010.9 1212.7
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분이익 N/AN/A 00.4 00.0 00.4 00.5
금융자산평가이익 N/AN/A 22.4 22.3 11.1 00.9
파생상품이익 N/AN/A 8181.3 8181.3 8585.6 8282.8
기타 N/AN/A 00.0 00.0 00.0 00.0
금융비용 N/AN/A 192192.7 198198.0 183183.5 179179.2
이자비용 N/AN/A 33.1 33.0 22.8 22.6
외환거래손실 N/AN/A 88.4 1414.0 22.2 00.9
외환차손 N/AN/A 33.0 11.6 11.6 00.9
외화환산손실 N/AN/A 55.4 1212.3 00.6 N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손상각비 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
금융자산평가손실 N/AN/A 00.5 00.6 00.6 00.6
파생상품손실 N/AN/A 162162.6 162162.3 159159.7 156156.9
기타 N/AN/A 1818.0 1818.0 1818.0 1818.0
기타영업외손익 N/AN/A 66.6 44.8 0-0.5 0-0.3
기타영업외수익 N/AN/A 77.0 44.7 88.4 88.0
이자수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
수수료수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
배당금수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
임대료 N/AN/A 00.0 00.1 00.2 00.1
로열티수익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자부동산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분이익 N/AN/A 00.8 00.8 55.9 55.9
무형자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타자산처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
대손충당금환입 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산평가이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
채무면제이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 66.1 33.8 22.2 11.9
기타영업외비용 N/AN/A 00.3 00.0 88.9 88.4
이자비용 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환거래손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외환차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
외화환산손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타대손상각비 N/AN/A 00.0 00.0 00.4 N/AN/A
기부금 N/AN/A 00.5 00.5 00.5 00.5
투자부동산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
투자자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
유형,리스자산처분손실 N/AN/A 0-0.2 0-0.2 N/AN/A 00.0
무형자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타자산처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
파생상품손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
자산평가손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
사채상환손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A 00.0 0-0.3 77.9 77.9
종속기업및관계기업관련손익 N/AN/A -2-2.1 -2-2.1 N/AN/A N/AN/A
지분법손익 N/AN/A -2-2.1 -2-2.1 N/AN/A N/AN/A
지분법이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
지분법손실 N/AN/A -2-2.1 -2-2.1 N/AN/A N/AN/A
지분법적용투자주식손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업관련손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업처분손실 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
종속기업손상차손 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
법인세비용차감전계속사업이익 N/AN/A 199199.1 190190.6 217217.2 176176.6
법인세비용 N/AN/A -9-9.5 -15-15.1 -16-16.5 11.5
중단사업이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
당기순이익 199199.9 208208.6 205205.8 233233.8 175175.1
지배지분 순이익 N/AN/A 160160.5 162162.0 196196.0 141141.5
비지배지분 순이익 N/AN/A 4848.1 4343.7 3737.8 3333.5
기타포괄이익 N/AN/A -12-12.1 -17-17.1 -10-10.4 -11-11.7
금융자산평가손익 N/AN/A 22.4 N/AN/A N/AN/A N/AN/A
매도가능금융자산평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
관계기업등기타포괄이익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
해외사업환산손익 N/AN/A 22.9 00.1 66.1 55.6
현금흐름위험회피적립금 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
재평가손익 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타포괄이익관련법인세 N/AN/A N/AN/A N/AN/A N/AN/A N/AN/A
기타 N/AN/A -17-17.5 -17-17.3 -16-16.6 -17-17.4
총포괄이익 N/AN/A 196196.5 188188.6 223223.3 163163.3
지배지분 총포괄이익 N/AN/A 146146.9 145145.1 185185.2 129129.5
비지배지분 총포괄이익 N/AN/A 4949.6 4343.5 3838.1 3333.8
주당순이익 N/AN/A 262262.7 265265.9 322322.1 233233.1
시가총액 N/AN/A 4,0744,074.3 4,1624,162.3 4,2634,263.4 4,2344,234.7
주가 N/AN/A 6,7306,730.0 6,8806,880.0 7,0907,090.0 7,3107,310.0
주가수익배수 N/AN/A 25.3925.39 25.6825.68 21.7521.75 29.9329.93
주식수(만주) N/A 6,164 6,050 6,013 5,830 5,793 5,793 5,793 5,793 5,793 5,793 5,793 5,793 5,793 5,793 5,745 5,745 5,564 4,992 4,992 4,992 4,992 4,992 4,992 4,992 N/A N/A N/A N/A N/A

20년 재무제표를 한번에! 프리미엄 서비스를 무제한으로 이용하세요. 프리미엄 55% 평생할인

밸류라인 서비스를 무제한 이용하세요 프리미엄